This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,…
Successfully completed a Phase 1 dose-escalation study demonstrating pan-mutant clinical activity, 95% target engagement and no grade 3 or 4…
SOMERVILLE, Mass., Jan. 9, 2025 /PRNewswire/ -- Generate:Biomedicines ("Generate") today announced that Mike Nally, Chief Executive Officer, will provide an…
Mark Orsmond, a highly respected business professional in Canadian Healthcare, Appointed Executive ChairMichael Nemirow Joins as Director, Bringing Decades of…
FMC-220 is a first-in-class covalent activator of p53Y220C designed to address potency and tolerability challenges of non-covalent approachesIn preclinical studies,…
BOSTON and SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation (“Frontier” or the “Company”), a…
Premier International Conference & Expo To Bring Together 3,000 Life Sciences and IT Leaders Focused on Advancing Precision Medicine BOSTON,…
Research Published in Radiology Shows that Combination of Transpara-based Lesion Detection, Volumetric Density and Quantitative Texture Analysis Delivers Improved Breast…
JACKSONVILLE, FLORIDA / ACCESSWIRE / January 8, 2025 / TriageLogic, a leader in telehealth triage solutions, has announced two major…
SANTA CRUZ, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to…